September 16, 2009
HHS Secretary Kathleen Sebelius announced Tuesday FDA approval for the use of the H1N1 vaccines from Novartis, Sanofi, CSL and MedImmune. Approval is also expected for GSK shortly. All will require just one dose based upon current findings in ongoing trials.
Mark M. Blatter, M.D.
Medical Director
Primary Physicians Research